Trials / Completed
CompletedNCT01645800
Effects of Lysozyme on Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study
Effects of Lysozyme On Acute Exacerbation of Chronic Obstructive Pulmonary Disease : A Randomised Placebo-Controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 408 (actual)
- Sponsor
- Eisai Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 84 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to assess the effectiveness in preventing exacerbation of 52 weeks lysozyme administration in patients with COPD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lysozyme hydrochloride | LYL 90mg capsule: Three times daily for 52 weeks. |
| DRUG | Placebo | Matching Placebo capsule: Three times daily for 52 weeks. |
Timeline
- Start date
- 2012-08-01
- Primary completion
- 2015-01-01
- Completion
- 2015-03-01
- First posted
- 2012-07-20
- Last updated
- 2015-10-21
Locations
25 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01645800. Inclusion in this directory is not an endorsement.